Why Aren’t We Listening to People in Sustained Addiction Recovery?

# The question

If we want to understand what leads to stable recovery, why aren't we spending more time listening to people who have achieved it? Dr. Larry Smith asks this directly. He points out that other health outcomes—like cancer survivorship or sports championships—are routinely studied by talking to those who've succeeded. Addiction recovery should be no different.

# What 'recovery' often overlooks

Contemporary discussions tend to emphasize measurable clinical outcomes: days of abstinence, treatment retention, overdose rates, or medication engagement. Those measures matter, but they don't capture whether someone rebuilt a life. Smith lists concrete dimensions that should be part of recovery assessment: repairing family relationships, steady employment, education, financial independence, volunteering, community participation, trust, friendships, purpose and meaning.

# Multiple pathways to recovery

# The role of medication and harm reduction

Smith acknowledges medication and harm reduction as important clinical tools that save lives and stabilize people. But he argues they are tools rather than definitions of recovery. Treatment that stabilizes someone—medication, housing, mental health care—is necessary, yet it should not exhaust our imagination for long-term recovery goals.

# The case for peer voices and mutual support

Smith asks why mutual-support organizations like Alcoholics Anonymous and Narcotics Anonymous, and peer supports with decades of recovery, are often sidelined in wider conversations. He argues that people who have lived through addiction and rebuilt their lives offer something unique: testimony that change is possible and concrete examples of what rebuilding looks like. That lived experience can complement clinical guidance and policy documents.

# Practical implications

• Broaden outcome metrics to include social, occupational and relational indicators.
• Include people in sustained recovery as partners in research, program design and policy discussions.
• Treat medications and harm-reduction services as parts of a broader recovery toolkit, not the sole endpoint.
• Support and fund long-term peer recovery networks and mutual-support organizations alongside clinical services.

# Bottom line

Listening to people who have sustained recovery yields practical knowledge about what works in real lives. Combining those lived experiences with clinical tools and harm-reduction measures gives a fuller, more useful picture of recovery and how to support it.